AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA

7 registrations across 3 African markets— 7 active

Markets with METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA

Recent registrations

Brand / ProductMarketHolderStatusExpires
Mircera 75 mcg**
Solution for injection
🇳🇬NigeriaRoche Products LimitedactiveJul 2028
Mircera 50 mcg**
Solution for injection
🇳🇬NigeriaRoche Products LimitedactiveJul 2028
MIRCERA
SOLUTION; INJECTION
🇿🇼ZimbabweROCHE PRODUCTS (PTY) LTDactiveDec 2027
MIRCERA
INJECTABLE; INJECTION
🇿🇼ZimbabweROCHE PRODUCTS (PTY) LTDactiveDec 2027
MIRCERA
SOLUTION; INJECTION
🇿🇼ZimbabweROCHE PRODUCTS (PTY) LTDactiveDec 2027
MIRCERA 75 MCG/0,3 ML SOLUTION INJECTABLE EN IV/SC BOITE DE 1 SERINGUE PRE-REMPLIEDE 0,3ML🇨🇮Côte d'IvoireF. HOFFMANN-LA ROCHE LTDactiveJul 2026
MIRCERA 50 MCG/0,3 ML SOLUTION INJECTABLE EN IV/SC BOITE DE 1 SERINGUE PRE-REMPLIE DE 0,3ML🇨🇮Côte d'IvoireF. HOFFMANN-LA ROCHE LTDactiveJul 2026

METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA in Africa — Regulatory Overview

METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Côte d'Ivoire, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.